This report contains market size and forecasts of Sympathomimetic Agents in Global, including the following market information:
Global Sympathomimetic Agents Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Sympathomimetic Agents market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Dobutamine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sympathomimetic Agents include Pfizer, Sanofi, Novartis, Sterimax, Bedford Pharmaceuticals, Teva, Amneal Biosciences, Baxter Laboratories and Hikma Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sympathomimetic Agents companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sympathomimetic Agents Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Sympathomimetic Agents Market Segment Percentages, by Type, 2021 (%)
Dobutamine
Dopamine
Ephedrine
Epinephrine
Isoproterenol
Mephentermine
Metaraminol
Methoxamine
Norepinephrine
Phenylephrine
Global Sympathomimetic Agents Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Sympathomimetic Agents Market Segment Percentages, by Application, 2021 (%)
Anaphylaxis
Cardiac Arrest
Others
Global Sympathomimetic Agents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Sympathomimetic Agents Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sympathomimetic Agents revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Sympathomimetic Agents revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Sanofi
Novartis
Sterimax
Bedford Pharmaceuticals
Teva
Amneal Biosciences
Baxter Laboratories
Hikma Pharmaceuticals
Amphastar Pharmaceuticals
Marathon Pharmaceuticals
Bausch Health Companies
Sterling-Winthrop
Cipla USA
Nexus Pharmaceuticals
Mylan
Impax
ALK Abello
Lincoln Medical
Amphastar
Emerade
Grand Pharma
Harvest Pharmaceuticals
Merit Pharmaceutical
Tianjin Jinyao Group